IP Library Granted Patent US 7,964,201
Granted Patent B2
US 7,964,201 · App. 11/128,020 · Granted Jun 21, 2011

Personal care compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,964,201
App. No.
11/128,020
Granted
Jun 21, 2011
Kind
B2
Abstract

A concentrate including, by weight (a) 10% to 60%, preferably 25% to 35%, of a saturated fatty acid selected from stearic or palmitic acid, or mixtures thereof, in an adduct of an amidopropyldimethyl-2-hydroxyethyl ammonium halide, with substantially no free acid present, and (b) 40% to 90%, preferably 65% to 75%, of a low molecular weight alcohol or saturated fatty alcohol or alcohols, for use in personal care products, including hair care and skin care compositions.

Claims (19)

1. A concentrate comprising, by weight, (a) 25% to 35% of a saturated fatty acid selected from stearic or palmitic acid, or mixtures thereof, in an adduct of an amidopropyldimethyl-2-hydroxyethyl ammonium halide, with substantially no free acid present, and (b) 65% to 75% of an alcohol, selected from a low molecular weight alcohol or a saturated fatty alcohol or alcohols, or mixtures thereof wherein the concentrate has a residual ethylene chlorohydrin level of <100 ppm.

2. A concentrate according to claim 1 wherein (b) is cetearyl or behenyl alcohol, or a mixture thereof, or propylene glycol, butylene glycol or isopropyl alcohol.

3. A concentrate according to claim 1 wherein (a) is about 30% and (b) is about 70%.

4. A concentrate according to claim 2 wherein (b) is a mixture of about half of cetearyl and half of behenyl alcohols.

5. A concentrate according to claim 1 which is made by reacting stearic or palmitic acid, or mixtures thereof, with 3-dimethylaminopropyl amine (DMAPA), at a first temperature of 160° to 170° C., until the conversion of acid to adduct is 97-99%, removing excess DMAPA under vacuum, cooling the contents, charging the low molecular weight alcohol or saturated fatty alcohol or alcohols and 2-chloroethanol (ethylene chlorohydrin, ECH), and heating to a second temperature of 145 to 155° C., and removing ECH under vacuum at a wall temperature of 140° C. or below.

6. A concentrate according to claim 5 wherein the free fatty acid is <1%.

7. A concentrate according to claim 5 wherein the residual ethylene chlorohydrin level is <10 ppm.

8. A concentrate according to claim 5 wherein the residual ethylene chlorohydrin level is <1 ppm.

9. A formulation including the concentrate of claim 1 which is a hair or skin care formulation.

10. A formulation according to claim 9 including 0.1-20% by weight of said concentrate.

11. A formulation according to claim 10 including 1-10% of said concentrate.

12. A formulation according to claim 11 including 2-5% of said concentrate.

13. A hair care formulation according to claim 9 which is a shampoo, conditioner, rinse, styling lotion, leave-in conditioner, gel, mousse, hair spray, styling cream, non-aerosol mousse, hair dye, relaxer, detangler or perm.

14. A hair care formulation according to claim 13 which includes a polymer and/or a surfactant.

15. A skin care formulation according to claim 9 which is a cream, lotion, moisturizing spray, sunscreen formula, alpha-hydroxy acid lotion, or body wash.

16. A skin care formulation according to claim 15 which includes a polymer and/or a surfactant.

17. A formulation according to claim 9 which provides structurant properties therein.

18. A formulation according to claim 9 which provides a delivery system for actives.

19. A concentrate according to claim 1 wherein the concentrate has a residual level of DMAPA of 0.1% or less.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CONVERSION Recorded Jan 30, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 041556/0499 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded Mar 18, 2013
From: THE BANK OF NOVA SCOTIA
To: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; AQUALON COMPANY; ISP INVESTMENTS INC.; HERCULES INCORPORATED
Reel/Frame 030025/0320 →
PATENT RELEASE Recorded Sep 19, 2011
From: JPMORGAN CHASE BANK, N.A. (F/K/A THE CHASE MANHATTAN BANK)
To: ISP CAPITAL, INC.; ISP CHEMICAL PRODUCTS, INC.; VERONA, INC.
Reel/Frame 026930/0774 →
SECURITY AGREEMENT Recorded Sep 16, 2011
From: ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC; HERCULES INCORPORATED; AQUALON COMPANY; ISP INVESTMENT INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 026918/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2005
From: BERTZ, STEVEN H.; MAKAROVSKY, ILYA
To: ISP INVESTMENTS INC.
Reel/Frame 016567/0420 →